ICAM-1 expression is increased in models of type 1 and 2 diabetes [22, 23] and can be induced by hyperglycemia, advanced glycosylation end products, oxidative stress, hyperlipidemia, hyperinsulinemia, and proinflammatory cytokines [24]. Here, ICAM1 is linked to Hyperglycemia.